Validation of the RBD Symptom Severity Scale in the North American Prodromal Synucleinopathy Consortium

Abstract

We describe the RBDSSS with adequate psychometric and clinimetric properties to quantify RBD symptom severity and good concordance between participant and bedpartner questionnaires and between RBDSSS scores and clinician-assessed global severity.